Smith Graham & Co Investment Advisors’s Sabra Healthcare REIT SBRA Stock Holding History

Smith Graham & Co Investment Advisors’s Portfolio SBRA Stock Details SBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-347,292	Closed	-$5.72M	–	133
2018 Q4	$5.72M	Sell	347,292 -18,090	-5%	-$364K	0.7%	62
2018 Q3	$8.45M	Sell	365,382 -7,870	-2%	-$178K	0.8%	48
2018 Q2	$8.11M	Sell	373,252 -1,270	-0.3%	-$24.8K	0.76%	51
2018 Q1	$6.61M	Sell	374,522 -7,490	-2%	-$132K	0.64%	82
2017 Q4	$7.17M	Buy	382,012 +7,510	+2%	+$149K	0.67%	73
2017 Q3	$8.22M	Sell	374,502 -3,730	-1%	-$84.3K	0.86%	45
2017 Q2	$9.12M	Buy	378,232 +74,447	+25%	+$1.89M	0.99%	29
2017 Q1	$8.48M	Buy	303,785 +86,950	+40%	+$2.28M	0.91%	36
2016 Q4	$5.29M	Buy	+216,835	New	+$4.97M	0.57%	79

Other funds holding SBRA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

CIM

Centersquare Investment Management Conshohocken, Pennsylvania $9.67B AUM 5.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Smith Graham & Co Investment Advisors's SBRA Position: Q1 2019 in Review

Smith Graham & Co Investment Advisors sold out of Sabra Healthcare REIT (SBRA) in Q1 2019, closing a stake of 347,292 shares — an estimated $5.72M sold.

Smith Graham & Co Investment Advisors first reported a position in SBRA in Q4 2016 and held it in 9 quarters. The position peaked at $9.12M in Q2 2017. 321 funds tracked by Wall St. Rank hold SBRA as of Q1 2019.

Smith Graham & Co Investment Advisors reported no remaining Sabra Healthcare REIT position as of Q1 2019 after selling out during the quarter.
Smith Graham & Co Investment Advisors sold 347,292 Sabra Healthcare REIT shares in Q1 2019, an estimated $5.72M.
Smith Graham & Co Investment Advisors first reported a position in Sabra Healthcare REIT in Q4 2016 and held it in 9 quarters.
Smith Graham & Co Investment Advisors's Sabra Healthcare REIT position peaked at $9.12M in Q2 2017.
321 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q1 2019.

Based on Smith Graham & Co Investment Advisors's 13F filing for Q1 2019, filed 23 Apr 2019.